Adrenaline 150 microgram auto-injector validation process no longer required

Adrenaline 150 microgram auto-injector validation process no longer required

November 28, 2018

From Thursday 29th November, adrenaline 150microgram auto-injectors will no longer be subject to additional validation processes.

The Department of Health and Social Care (DHSC) has stated that stock levels are now at a level where the validation protocol put in place in October, and revised earlier this month, is no longer required.*

Community pharmacy teams will, therefore, be permitted to dispense the total number of adrenaline 150microgram auto-injectors prescribed to each patient. However, whilst stock filters through the supply chain, some wholesalers may still apply a restriction to ordering levels. Pharmacy teams may wish to discuss this with their usual wholesaler.

PSNC will continue to monitor the supply of adrenaline auto-injectors and will support DHSC and NHS England in their efforts to ensure the return to normal dispensing runs smoothly.

*Please note, EpiPen products were subject to prescription validation prior to the protocol introduced October and this will continue as before, pharmacies will be able to order up to a maximum of two EpiPen Junior devices per prescription.

Posted in: ,

More Latest News >

NUMSAS: are you claiming correctly?

Following the extension of the NHS Urgent Medicine Supply Advanced Service (NUMSAS) pilot until September 30th 2019, community pharmacy contractors...

DHSC EU Exit Communication

Community pharmacy teams will be aware that Government has agreed a further extension of the EU exit date to 31st...

Shortage of Labetalol tablets

Specialist Pharmacy Service (SPS) advises that there is currently a shortage of Labetalol 50mg, 100mg, 200mg and 400mg tablets. The...